HAE · Healthcare
HAEMONETICS CORP MASS
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
37
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in HAEMONETICS CORP MASS? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$3.6B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About HAEMONETICS CORP MASS
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers…
Who's behind the signal
Every informed buyer we can see on HAE, across all three feeds.
Hedge funds · 7
Tudor Investment (Paul Tudor Jones)
New position
D.E. Shaw & Co
New position
AQR Capital Management
Increased +49%
Point72 (Steve Cohen)
Increased +1882%
Citadel Advisors
Increased +482%
Gotham Asset Mgmt (Greenblatt)
Decreased −18%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 10
Every disclosed buy & sell on record — STOCK Act filings
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-05-07 | Lois Frankel · D-FL | House | SOLD | $1,001 - $15,000 |
| 2021-05-06 | Lois Frankel · D-FL | House | SOLD | $1,001 - $15,000 |
| 2021-01-25 | Josh Gottheimer · D-NJ | House | SOLD | $1,001 - $15,000 |
| 2020-10-16 | Josh Gottheimer · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2020-09-15 | Josh Gottheimer · D-NJ | House | SOLD | $1,001 - $15,000 |
| 2020-08-14 | Lois Frankel · D-FL | House | BOUGHT | $1,001 - $15,000 |
| 2020-06-01 | Gilbert Ray Cisneros, Jr. · D-CA | House | BOUGHT | $1,001 - $15,000 |
| 2020-05-28 | Josh Gottheimer · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2020-05-19 | Gilbert Ray Cisneros, Jr. · D-CA | House | BOUGHT | $1,001 - $15,000 |
| 2020-05-15 | Josh Gottheimer · D-NJ | House | BOUGHT | $1,001 - $15,000 |
Not a model pick — but on our radar.
HAEMONETICS CORP MASS isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
2
New positions
3
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
0.0%
Position change
NEW
0.0% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
NEW
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+49%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+1882%
0.1% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+482%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
−18%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−93%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to HAEMONETICS CORP MASS
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell HAEMONETICS CORP MASS or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime